36494352|t|Defective proteostasis in induced pluripotent stem cell models of frontotemporal lobar degeneration.
36494352|a|Impaired proteostasis is associated with normal aging and is accelerated in neurodegeneration. This impairment may lead to the accumulation of protein, which can be toxic to cells and tissue. In a subset of frontotemporal lobar degeneration with tau pathology (FTLD-tau) cases, pathogenic mutations in the microtubule-associated protein tau (MAPT) gene are sufficient to cause tau accumulation and neurodegeneration. However, the pathogenic events triggered by the expression of the mutant tau protein remain poorly understood. Here, we show that molecular networks associated with lysosomal biogenesis and autophagic function are disrupted in brains from FTLD-tau patients carrying a MAPT p.R406W mutation. We then used human induced pluripotent stem cell (iPSC)-derived neurons and 3D cerebral organoids from patients carrying the MAPT p.R406W mutation and CRISPR/Cas9, corrected controls to evaluate proteostasis. MAPT p.R406W was sufficient to induce morphological and functional deficits in the lysosomal pathway in iPSC-neurons. These phenotypes were reversed upon correction of the mutant allele with CRISPR/Cas9. Treatment with mTOR inhibitors led to tau degradation specifically in MAPT p.R406W neurons. Together, our findings suggest that MAPT p.R406W is sufficient to cause impaired lysosomal function, which may contribute to disease pathogenesis and serve as a cellular phenotype for drug screening.
36494352	66	99	frontotemporal lobar degeneration	Disease	MESH:D057174
36494352	177	194	neurodegeneration	Disease	MESH:D019636
36494352	308	360	frontotemporal lobar degeneration with tau pathology	Disease	MESH:D057174
36494352	362	370	FTLD-tau	Disease	MESH:D057174
36494352	407	437	microtubule-associated protein	Gene	51115
36494352	438	441	tau	Gene	4137
36494352	443	447	MAPT	Gene	4137
36494352	478	481	tau	Gene	4137
36494352	499	516	neurodegeneration	Disease	MESH:D019636
36494352	591	594	tau	Gene	4137
36494352	757	765	FTLD-tau	Disease	MESH:D057174
36494352	766	774	patients	Species	9606
36494352	786	790	MAPT	Gene	4137
36494352	791	798	p.R406W	ProteinMutation	tmVar:p|SUB|R|406|W;HGVS:p.R406W;VariantGroup:0;CorrespondingGene:4137;RS#:63750424;CorrespondingSpecies:9606;CA#:225495
36494352	822	827	human	Species	9606
36494352	912	920	patients	Species	9606
36494352	934	938	MAPT	Gene	4137
36494352	939	946	p.R406W	ProteinMutation	tmVar:p|SUB|R|406|W;HGVS:p.R406W;VariantGroup:0;CorrespondingGene:4137;RS#:63750424;CorrespondingSpecies:9606;CA#:225495
36494352	1018	1022	MAPT	Gene	4137
36494352	1023	1030	p.R406W	ProteinMutation	tmVar:p|SUB|R|406|W;HGVS:p.R406W;VariantGroup:0;CorrespondingGene:4137;RS#:63750424;CorrespondingSpecies:9606;CA#:225495
36494352	1237	1241	mTOR	Gene	2475
36494352	1260	1263	tau	Gene	4137
36494352	1292	1296	MAPT	Gene	4137
36494352	1297	1304	p.R406W	ProteinMutation	tmVar:p|SUB|R|406|W;HGVS:p.R406W;VariantGroup:0;CorrespondingGene:4137;RS#:63750424;CorrespondingSpecies:9606;CA#:225495
36494352	1350	1354	MAPT	Gene	4137
36494352	1355	1362	p.R406W	ProteinMutation	tmVar:p|SUB|R|406|W;HGVS:p.R406W;VariantGroup:0;CorrespondingGene:4137;RS#:63750424;CorrespondingSpecies:9606;CA#:225495
36494352	Association	MESH:D057174	RS#:63750424;HGVS:p.R406W;CorrespondingGene:4137
36494352	Association	2475	4137
36494352	Association	MESH:D057174	4137
36494352	Association	MESH:D019636	4137
36494352	Association	MESH:D057174	4137

